Perioperative Control of Acute High Blood Pressure in Neurosurgical Patients Admitted to Intensive Care Unit Using Clevidipine (NEURO-CLEV)

Abstract

Escontrela Rodriguez Blanca55182*, Acevedo Bambaren Ismael55183, Arana-Arri Eunate55184, Maroño Boedo Maria Jesús55186, Guereca Gala Ane55187 and Martinez Ruiz Alberto55188

Background: Effective treatment of hypertension in neurocritical diseases is a current recommendation of guidelines. Clevidipine had showed effectiveness and safety for hypertension control in neurocritical patients.

Methods: Retrospective, observational and cross-sectional study in adult patients admitted to Intensive Care Unit for neurocritical disease requiring surgical or interventional treatment and presenting hypertension requiring urgent treatment with clevidipine as first line or rescue therapy after failure of different intravenous antihypertensive drugs. This study aimed to observe effectiveness and safety of clevidipine treatment in these patients. We conducted a subgroup analysis to observe possible confounder factors on effectiveness and safety of clevidipine treatment, major neurological complications and mortality.

Results: Thirty-three patients fulfilled inclusion criteria. Clevidipine was effective and safety for urgent control of hypertension in our patients. Effectiveness was higher in patients with larger brain hematomas and more severe subarachnoid hemorrhages treated with clevidipine as first line beginning within first 24 hours of admission. Subgroup of patients under effective treatment with clevidipine showed a slightly lower incidence of major neurological complications and mortality than global group. Early treatment within 24 hours of admission subgroup showed a lower incidence of major neurological complications than global group. No mortality was observed when clevidipine was first line treatment.

Conclusion: Clevidipine was effective and safe treatment of hypertension in our neurocritical patients. Severity of neurocritical disease is a key factor but effective treatment with clevidipine could contribute to reduce mortality and major neurological complications. Early treatment could prevent major neurological complications. First line treatment with clevidipine could reduce mortality. Nevertheless, our results based in a little size and retrospective study warranting further investigation in larger trials.

Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3